Skip to main content

WELLS FARGO & COMPANY/MN

Position in GKOS — GLAUKOS Corp

CIK 72971 SAN FRANCISCO, CA

Position in GKOS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,115,284
+$5,933,179 QoQ
Shares Held
65,221
+120.7% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 364 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GKOS Over Time

Shares Held

Position Value (USD)

Derivatives in GKOS

reported options exposure · as of Dec 31, 2024
CallValue
$5,262,894
CallShares
35,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $3,522,935,622 across 102 Medical Devices names. GKOS ranks #20 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GKOS

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,115,284 65,221
2026-03-31 $3,182,105 29,557
2025-12-31 $7,810,548 69,175
2025-09-30 $3,327,890 40,808
2025-06-30 $3,669,169 35,523
2025-03-31 $3,472,550 35,283
2024-12-31 $4,874,848 32,512
2024-12-31 $5,262,894 35,100
2024-09-30 $3,272,631 25,120
2024-06-30 $2,879,335 24,329
2024-03-31 $1,798,108 19,070
2023-12-31 $1,468,178 18,470
2023-09-30 $847,239 11,259
2023-06-30 $1,701,633 23,896
2023-03-31 $668,733 13,348
2022-12-31 $213,506 4,888
2022-09-30 $378,162 7,103
2022-06-30 $375,485 8,267
2022-03-31 $1,551,598 26,835
2021-12-31 $9,464,829 212,980
2021-09-30 $10,137,518 210,453
2021-06-30 $7,115,537 83,880
2021-03-31 $6,247,495 74,437
2020-12-31 $7,374,274 97,984
2020-09-30 $9,191,505 185,612
2020-06-30 $5,917,254 154,015
2020-03-31 $4,253,740 137,840